http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103860552-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
filingDate | 2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103860552-B |
titleOfInvention | The application in preparing anti-HIV-1 virus drugs of a kind of antiviral compound |
abstract | The present invention is claimed the application in preparing AntiHIV1 RT activity 1 virus drugs of a kind of XX compounds, and the structural formula of described XX compounds is as shown in Formulas I, Formula II or formula III: Formulas I R 1 For Cl, CF 3 、OCF 3 、COOMe、Me、t‑Butyl、OMe、N(Me) 2 Or SMe, R 2 For Cl, Me or H; Formula II; Formula III.The compound that the present invention provides is respectively provided with preferable antivirus action, the strong theoretical basis provided for the research and development of further antiviral drugs and practical basis, has important research and development value and development significance. |
priorityDate | 2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.